Vivera is an innovative, science-driven pharmaceutical company focused on novel therapies for a variety of indications. In addition to its pharmaceutical, medical device, advanced diagnostics, medical supplies, medical technologies, and neurosciences, the Company has global exclusivity to license the patented and patent-pending TABMELT®️ sublingual drug-delivery system for the pharmaceutical use of therapeutic compounds. Vivera is vertically integrated with technology, manufacturing capabilities, and distribution for its products.
Vivera is committed to the continued research and development of innovative therapies across the spectrum. We believe that now is the time to combat some of the most unprecedented issues affecting patients and their caregivers by redefining the landscape with safe, yet effective, non-addictive treatment alternatives for pain management and the latest in medical device technologies. From strength in vision to channeled realization, we believe the path forward begins with the requirement to put patients first. Our foremost mission is to enhance the lives of millions of neighbors, families, and the leaders of tomorrow, through ceaseless development of life-changing new therapies.
Vivera is dedicated to making a positive difference for vulnerable communities across the world. Through our non-profit organization, Vivera Cares, we are helping underserved communities, like Tribal Nations and frontline workers, access the resources they need to keep their communities safe and healthy. With our continued support, we can envision a brighter future for our communities, patients, and providers.
Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a brand of LuSys Laboratories or as
NEWPORT BEACH, Calif. Vivera Pharmaceuticals announced today, the appointment of Donald D’Ambrosio as the Company’s Chief Financial Officer (CFO). With over four decades of experience serving in executive and officer
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals is pleased to announce the Company’s Chairman and CEO, Paul Edalat, has joined the Forbes Business Council, an invitation-only
NEWPORT BEACH, Calif. — Vivera Pharmaceuticals announced today that it would be testing at Univision’s “The Spirit of Giving” Toy Drive Saturday, December 4th, in Huntington Park. Univision’s Toy Drive is more than a
NEWPORT BEACH, Calif.— Vivera is proud to announce that it is the COVID-19 testing partner for 7G Foundation’s 2021 Indigenous Bowl sponsored by the National
Vivera Welcomes Former DEA Special Agent Executive to BioSciences Advisory Board
Vivera announced today that it has the solution to one of our nation’s most significant health challenges: the opioid crisis. Three of America’s biggest pharmacy chains
The opioid crisis is a significant public health crisis in the United States that is only worsening. According to preliminary data released by the Centers
About one in five U.S. adults live with a mental illness. One in 25 live with a serious mental illness. Despite its prevalence, there is
Did you know that pain is the number one reason Americans access the health care system? Chronic pain, which is pain that persists on most
Mental health has been a topic of interest in the sports world for a while, as an increasing number of athletes are stepping forward to
When people think about drug abuse, they often think about illicit drugs like heroin or cocaine. While these drugs are widely abused, many people also
Innovation is the lifeblood of Vivera. With six divisions, each focused on a specific crisis response, Vivera’s vertically integrated structure has created an agile and responsive model.
Vivera is working to change the future of drug delivery, medical device, and medical technologies at home and across the globe with its extensive intellectual property portfolio.
Copyright © 2021 Vivera Pharmaceuticals, Inc. All rights reserved.
This information – including product information – is intended only for certified clinicians in the United States. The products discussed herein may have different labeling in different countries. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
English
Arabic
Armenian
Chinese (Simplified)
Chinese (Traditional)
Czech
Dutch
Tagalog
French
Frisian
German
Irish
Italian
Korean
Farsi
Polish
Portuguese
Romanian
Russian
Spanish
Swedish
Ukrainian
Vietnamese